ALEXANDRIA, Va., March 26 -- United States Patent no. 12,257,266, issued on March 25, was assigned to The Regents of the University of California (Oakland, Calif.) and UNIVERSITY OF PITTSBURGH-OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION (Pittsburgh).
"Stem cell-derived exosomes for the treatment of corneal scarring" was invented by Sophie Xiaohui Deng (Los Angeles) and James L. Funderburgh (Pittsburgh).
According to the abstract* released by the U.S. Patent & Trademark Office: "Corneal stromal scars are the leading cause of corneal blindness. The present invention relates to methods and compositions useful in therapies for this pathological condition. The invention provides corneal stromal stem cells and certain other stem cells and as...